Biography:

Daniel Adams is Director of Clinical R&D at Creatv Bio, Division of Creatv MicroTech, Inc., and  currently a visiting scientist at Rutgers University, New Jersey. He received BS in Biochemistry-Molecular Biology from University of California Santa Barbara. Before joining Creatv MicroTech in 2007, he was Associate Research Scientist at SBH Sciences, a pre-clinical CRO for cancer drug development. He was first to publish the clinical applications of tumor macrophage fusion cells.  He has been lead author on 20 peer-reviewed publications, 7 co-authorships, and written 4 book chapters on bio-detection of rare analytes and liquid biopsies for cancer screening and cancer diagnostics.